Explore evidence

30 %The mean proportion of severe malaria cases reported between 2017 and 2022 was 30% in Mali.

Malipaludismeobserved 2017–2022HAL · Unilimdocument of 111 observations

5.04 per_1000_person_weeksFrom May 2024 to February 2025, children aged 0–11 months had 5.04 uncomplicated malaria cases per 1,000 person-weeks in the Kidal region.

Malipaludismeobserved 2024-2025HAL · Unilimdocument of 80 observations

1.53 %Au Mali, la proportion de mort-né est passée de 1,53 % à 2,06 % entre 2020 et 2023.

Malimort-néobserved 2020 à 2023HAL · Unilimdocument of 302 observations

1 per_100Au Mali, le taux de mortalité des enfants drépanocytaires de moins de 5 ans sous suivi médical a été réduit à moins de 1 %.

MalidrépanocytoseHAL · Unilimdocument of 857 observations

71 %In the non-SMC patient population, 220 out of 310 (71%) samples were successfully PCR analyzed in November 2014.

Malipaludismeobserved November 2014published 2016PloS oneeurope_pmcdocument of 4 observations

0.25 ORSeasonal malaria chemoprevention conveyed a significant protective effect against clinical malaria with an odds ratio of 0.25 in 2012 and 2014 in Koutiala, Mali.

Malipaludismepublished 2020International journal of environmental research and public healtheurope_pmcdocument of 7 observationsDOI 10.3390/ijerph17186639

56 %56% of mothers stated they would have recourse to modern medicine in front of a sickle cell disease crisis.

Malidrépanocytosepublished 2009Мир науки, культуры, образованияOpenAlexdocument of 12 observations

The proportion of patients with anemia significantly decreased compared to baseline.

Malianémiepublished 2021Tropical medicine and infectious diseaseeurope_pmcdocument of 3 observationsDOI 10.3390/tropicalmed6010013

150 per_1000_person-yearsMalaria incidence in Mali went from 150 to 172 per 1000 person-years between 2021 and 2022.

Malipaludismeobserved 2021HAL · Unilimdocument of 111 observations

41 %Parmi les 835 patients suspects de COVID-19, 353 (41 %) présentaient des critères mineurs de COVID-19.

MaliCOVID-19observed June 2022 and September 2022HAL · Unilimdocument of 36 observations

1 per_40000Branchio-otic syndrome has a global incidence of 1 per 40,000.

MaliBranchio-otic syndromepublished 2022Molecular genetics & genomic medicineeurope_pmcdocument of 7 observations

38.5 daysSulfadoxine-pyrimethamine treatment delayed the median time to first clinical malaria episode from 38.5 to 68 days.

Malipaludismepublished 2002The American journal of tropical medicine and hygieneeurope_pmcdocument of 4 observationsDOI 10.4269/ajtmh.2002.67.604

23 %The proportion of gametocyte carriers declined from 23% at baseline to 6% on day 21 in the 2010–2011 study.

Malipaludismeobserved 2010-2011published 2016Parasite (Paris, France)europe_pmcdocument of 5 observationsDOI 10.1051/parasite/2016003

3.24 %La prévalence globale des gamétocytes variait d’un mois à l’autre selon l’année, avec une prévalence moyenne de 3,24 % dans le dépistage passif.

MalipaludismeHAL · Unilimdocument of 214 observations

6.1 %Au Mali, la fréquence du trait drépanocytaire varie de 6,1 % dans les régions du nord à 15 à 20 % dans certaines régions du sud.

MalidrépanocytoseHAL · Unilimdocument of 202 observations

606 patientsA total of 606 patients were enrolled in the clinical trial, with 303 in each treatment arm.

Malipaludismeobserved 2003 and 2004published 2006The American journal of tropical medicine and hygieneeurope_pmcdocument of 4 observationsDOI 10.4269/ajtmh.2006.75.630

56 %In Mali, seasonal malaria chemoprevention reduced severe malaria by 56% with a relative risk of 0.44 and 95% confidence interval 0.22–0.91.

MalipaludismeHAL · Unilimdocument of 110 observations

18 out_of_21Among AMA1 recipients, 18/21 evaluable samples stimulated with AMA1 demonstrated increased IFN-γ, TNF-α, and IL-2 derived from CD4(+) T cells by day 150 compared to 0/10 in the control group.

Malipaludismepublished 2016Vaccineeurope_pmcdocument of 2 observations

100 per_1000_person_yearsDistricts with incidence rates between 100 and 250 cases per 1,000 person-years or Pf/Pv prevalence between 1% and 10% were classified as 'Low Transmission Zones'.

Malipaludisme · Pf/PvHAL · Unilimdocument of 95 observations

1.688 per_1000_person_weeksThe malaria epidemic in Kidal, Mali began in week 30, peaked in week 39 with 1,014 cases, and lasted for 28 weeks, with 1.688 cases per 1,000 person-weeks.

MalipaludismeHAL · Unilimdocument of 80 observations

0.62 per_1000_person_weeksFrom May 2024 to February 2025, children aged 5–14 years had 0.62 uncomplicated malaria cases per 1,000 person-weeks in the Kidal region.

Malipaludismeobserved 2024-2025HAL · Unilimdocument of 80 observations

200,000 parasites per microliterL’hyper-parasitémie (≥200000 parasites par μL de sang) observée avec P. falciparum conduit au paludisme grave.

MalipaludismeHAL · Unilimdocument of 214 observations

25 %Malaria has a mortality rate of 25% in Mali.

MalipaludismeHAL · Unilimdocument of 95 observations

7.24 %Infants aged 0–11 months accounted for 7.24% of total malaria cases in the Kidal region from week 23 in 2024 (May) to week 5 in 2025 (February).

Malipaludismeobserved 2024-2025HAL · Unilimdocument of 80 observations

33.5 %Seroprevalence of COVID-19 in the Tombouctou population was 33.5% (95% CI: 30.4% to 36.6%).

MaliCOVID-19HAL · Unilimdocument of 88 observations